Best DNA Test for Health Reports in 2026: What to Buy and What to Know First

Buying a DNA test for health reports is a fundamentally different decision from buying one for ancestry. The product you get is an interpretation of your DNA in the context of published research, and the value depends on which variants the company tests, how they report risk, and what you do with the result. Our job here is to help you pick a test. Our job is not to tell you what any result means for you. For that, talk to a board-certified genetic counselor through the National Society of Genetic Counselors directory.

We compared the three categories of consumer health-DNA product available in early 2026: a sample-collection kit with built-in FDA-authorized health reporting, a third-party analysis platform that interprets raw data you upload, and a whole-genome sequencing product whose data can drive a wide range of third-party reports.

Most established: 23andMe (with caveats)

23andMe is the only consumer test that ships with FDA-authorized reports on certain carrier statuses and a specific list of health predispositions. That authorization is a meaningful quality signal: the FDA evaluated the clinical and analytical validity of the specific variants the company tests for those reports. As of early 2026, no other consumer ancestry-plus-health kit carries the same authorization profile.

Two important caveats. First, 23andMe filed Chapter 11 in March 2025 and its genetic data and core consumer assets were transferred to TTAM Research Institute in mid-2025. The consumer service still operates, but corporate stability is uncertain. Read the genetic data privacy guide in full before mailing a kit. Second, an FDA-authorized report covers a narrow set of variants for a narrow set of conditions. It is not a full clinical genetic workup, and the conditions reported do not represent your entire genetic risk picture for any disease.

Historically the Ancestry + Health tier ran $199 and up; verify the current price on the live site given the post-bankruptcy changes.

Best for interpreting raw data you already have: SelfDecode

SelfDecode is not primarily a sample-collection product. It is an analysis platform. You upload raw data from AncestryDNA, 23andMe, or another service, or buy one of its kits, and the platform produces a large library of health and wellness reports against that data. Pricing is largely subscription-based and changes frequently; check the current SelfDecode site before subscribing.

The model is genuinely useful for buyers who already tested with Ancestry or 23andMe and want a second, health-oriented interpretation of the same raw data without buying a second kit. Report scope and accuracy claims should be treated as the company’s claims rather than as clinical findings, and any specific result needs a credentialed conversation, not a chatbot.

Best for depth: Sequencing.com

Sequencing.com replaced Nebula Genomics as the active whole-genome sequencing option after Nebula shut down its consumer service in February 2025. A whole-genome product reads roughly your entire genome, around 3 billion base pairs, rather than the roughly 700,000 markers a typical genotyping array reads. That gives you a much richer underlying dataset for third-party health apps and future re-analysis as the science evolves.

Pricing varies by sequencing depth and promotion; obtain the current number from Sequencing.com directly rather than relying on any third-party figure, this one included.

What none of these tests are

Consumer health-DNA products are screening tools and educational reports. They are not diagnostic tests, they do not replace clinical genetic testing ordered by a doctor for a specific medical question, and they do not predict whether you will get a disease. A negative result on a carrier panel does not mean you are not a carrier of something the panel did not test for. A positive risk finding does not mean you will develop the condition.

If a report flags something that concerns you, the right next step is a board-certified genetic counselor through the NSGC directory, who can order confirmatory clinical testing if it is warranted and put any result in the right clinical context.

How we weighted these picks

We weighted regulatory standing and report quality above price, depth of data above breadth of marketing claims, and we treated corporate stability as a real factor given the 23andMe situation. For background on what the major tests actually do, our guide to DNA testing pillar walks through the categories, and our best DNA tests overall roundup covers ancestry use cases alongside health.

If a budget is the constraint, the best budget DNA test breakdown looks at the cheapest ways to get any kind of DNA result in your hands.